Stockscreener 앱 받기
412.70
2.93%
11.76
시간 외 거래:
411.70
-1.00
-0.24%
전일 마감가:
$400.94
열려 있는:
$401.92
하루 거래량:
2.08M
Relative Volume:
1.83
시가총액:
$89.50B
수익:
$201.11B
순이익/손실:
$4.95B
주가수익비율:
18.34
EPS:
22.4991
순현금흐름:
$6.29B
1주 성능:
+6.80%
1개월 성능:
+3.98%
6개월 성능:
+30.24%
1년 성능:
+15.24%
1일 변동 폭
$400.94
$418.56
1주일 범위
$385.00
$418.56
52주 변동 폭
$274.84
$436.24
엘리번스 헬스 Stock (ELV) Company Profile
명칭
Elevance Health Inc
전화
(800) 331-1476
주소
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
412.70 | 89.50B | 201.11B | 4.95B | 6.29B | 22.50 |
UNH
Unitedhealth Group Inc
|
379.30 | 340.46B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
86.16 | 110.20B | 407.94B | 2.90B | 7.39B | 2.2771 |
CI
Cigna Group
|
282.43 | 74.63B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
431.87 | 51.86B | 137.20B | 1.15B | 1.27B | 9.3439 |
엘리번스 헬스 Stock (ELV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-05-20 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-04-29 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2026-04-08 | 개시 | Evercore ISI | In-line |
| 2026-02-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 개시 | Goldman | Neutral |
| 2025-07-21 | 다운그레이드 | Argus | Buy → Hold |
| 2025-07-18 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | 업그레이드 | Argus | Hold → Buy |
| 2025-01-22 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-07-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-06-24 | 개시 | Morgan Stanley | Overweight |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2023-07-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-28 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
모두보기
엘리번스 헬스 주식(ELV)의 최신 뉴스
CVS Health Trades at a Discount to Industry: How to Play the Stock? - Zacks Investment Research
2 Stocks to Buy Hand Over Fist in October - The Motley Fool
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - Zacks Investment Research
UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore - Zacks Investment Research
Elevance Health stock sets October 21 earnings date - AD HOC NEWS
Third-quarter results are set for 6 a.m. Oct. 21, before Elevance Health's 8:30 a.m. call. - Stock Titan
Elevance Health, Inc. Actuals & Estimates (NYSE:ELV) - TradingView
ANTM5405194 Bond Profile: Coupon and Redemption - TradingView
Elevance Health Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year? - Zacks Investment Research
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year? - Yahoo Finance
Elevance Health, Inc. (ELV) Stock Forecasts - Yahoo Finance
Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Elevance Health (ELV): Conviction Pays Off as Underwriting Disciplines Stabilize Margins - Yahoo Finance
Elevance Health Unveils 2027 Medicare Advantage Plans, Ticker EL - GuruFocus
Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support - Business Wire
Elevance Health (ELV) Is Back In The Spotlight, What Is Drawing Attention? - Simply Wall Street
Elevance Health, Inc. (ELV) Stock forecasts - Yahoo Finance Singapore
ANTM5815521 Bond Profile: Coupon and Redemption - TradingView
ANTM3707029 Bond Profile: Coupon and Redemption - TradingView
ANTM3684374 Bond Profile: Coupon and Redemption - TradingView
Elevance Health's Quarterly Earnings Preview: What You Need to Know - inkl
Elevance Health's Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
AE1J Bond Profile: Coupon and Redemption - TradingView
Free cash flow per share of Elevance Health, Inc. – HAN:A58 - TradingView
Elevance Health on Pace for Longest Losing Streak Since September 2022 -- Data Talk - Moomoo
ANTM3670950 Bond Profile: Coupon and Redemption - TradingView
ANTM4880736 Bond Profile: Coupon and Redemption - TradingView
Elevance Health stock last trades at USD 393.56 on September 28, 2026 - AD HOC NEWS
ANTM5923066 Bond Profile: Coupon and Redemption - TradingView
Could Elevance Health (NYSE:ELV) Reset Its Market Story? - Kalkine Media
Elevance Health stock weighs a raised EPS outlook - AD HOC NEWS
ANTM3667634 Bond Profile: Coupon and Redemption - TradingView
The American Journal of Managed Care® announces Aaron L. Schwartz, M.D., Ph.D., as 2026 Emerging Leader in Managed Care Research Award recipient - GlobeNewswire Inc.
ANTM5405192 Bond Profile: Coupon and Redemption - TradingView
Elevance Health stock heads into the open after a 0.8 percent gain - AD HOC NEWS
Elevance Health stock carries a USD 27 adjusted EPS outlook - AD HOC NEWS
ANTM4983276 Bond Profile: Coupon and Redemption - TradingView
AM Best withdraws ratings of Elevance Health's Hawaii captive - Captive Insurance Times
AM Best withdraws ratings of Elevance Health's Hawaii captive - Captive Insurance Times
Elevance Health stock heads into the open after a 0.45 percent drop - AD HOC NEWS
How Centene's Strong Cash Flow Is Reshaping Its Balance Sheet - Zacks Investment Research
Gail Boudreaux | Elevance Health CEO & Former Dartmouth Basketball Star - Britannica
Elevance Health (ELV) Stock May Be Below Fair Value As Guidance Was Reaffirmed - Yahoo Finance
Elevance Health (ELV) Q2 2026 Earnings Call Transcript - Fortune
NY Surgeons Say Elevance Penalty Policy Is Anticompetitive - law360.com
Can Carelon Drive Elevance Health's Future Earnings Growth? - Eastern Progress
Elevance Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year? - Yahoo Finance
Elevance Health, Inc. (ELV) Stock forecasts - Yahoo Finance Australia
엘리번스 헬스 (ELV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
엘리번스 헬스 주식 (ELV) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BOUDREAUX GAIL | President and CEO |
Jul 17 '26 |
Buy |
367.79 |
2,725 |
1,002,230 |
171,976 |
| CLARK R KERRY | Director |
Jul 07 '26 |
Proposed Sale |
419.91 |
1,500 |
629,865 |
0 |
| Penczek Ronald W | CAO & Controller |
Jun 12 '26 |
Sale |
403.16 |
369 |
148,766 |
3,740 |
| RONALD WILLIAM PENCZEK | Officer |
Jun 12 '26 |
Proposed Sale |
403.16 |
369 |
148,767 |
0 |
| Dixon Robert L JR | Director |
Jun 11 '26 |
Proposed Sale |
401.76 |
151 |
60,666 |
0 |
| Dixon Robert L JR | Director |
Jun 11 '26 |
Sale |
401.77 |
151 |
60,667 |
10,734 |
| Penczek Ronald W | CAO & Controller |
May 19 '26 |
Option Exercise |
294.30 |
1,531 |
450,579 |
5,640 |
| Penczek Ronald W | CAO & Controller |
May 19 '26 |
Sale |
403.13 |
1,531 |
617,192 |
4,109 |
| RONALD WILLIAM PENCZEK | Officer |
May 19 '26 |
Proposed Sale |
403.13 |
1,531 |
617,192 |
0 |
| SCHULMAN AMY W | Director |
Mar 12 '26 |
Sale |
287.50 |
26 |
7,475 |
218 |
0.50%
1.87%
자본화:
|
볼륨(24시간):